Literature DB >> 21510737

Cardiopulmonary exercise testing in the assessment of pulmonary hypertension.

Ross Arena1, Marco Guazzi, Jonathan Myers, Daniel Grinnen, Daniel E Forman, Carl J Lavie.   

Abstract

The assessment of patients with suspected or confirmed pulmonary arterial hypertension (PAH) and secondary pulmonary hypertension (PH) continues to evolve and, in recent years, evidence demonstrating that cardiopulmonary exercise testing (CPX) provides valuable information has grown at an impressive rate. The key premise supporting the use of CPX is that certain variables obtained provide insight into the degree of ventilation/perfusion mismatching secondary to altered pulmonary hemodynamics. In this article, we discuss the pathophysiology of PAH and secondary PH and its impact on cardiac function, review the clinical presentation of patients with elevated pulmonary pressures and outline a case for the use of CPX as an integral assessment technique, discuss CPX technology and testing procedures, and review the current state of available evidence and provide clinical recommendations for CPX in the setting of known or suspected PAH and secondary PH.

Entities:  

Mesh:

Year:  2011        PMID: 21510737      PMCID: PMC7333863          DOI: 10.1586/ers.11.4

Source DB:  PubMed          Journal:  Expert Rev Respir Med        ISSN: 1747-6348            Impact factor:   3.772


  84 in total

1.  An experimental study of physical fitness of Air Force personnel.

Authors:  B BALKE; R W WARE
Journal:  U S Armed Forces Med J       Date:  1959-06

2.  Pathophysiological adaptations to walking and cycling in primary pulmonary hypertension.

Authors:  G Valli; C D Vizza; P Onorati; R Badagliacca; R Ciuffa; R Poscia; F Brandimarte; F Fedele; P Serra; P Palange
Journal:  Eur J Appl Physiol       Date:  2007-11-03       Impact factor: 3.078

3.  Assessment of functional capacity in clinical and research settings: a scientific statement from the American Heart Association Committee on Exercise, Rehabilitation, and Prevention of the Council on Clinical Cardiology and the Council on Cardiovascular Nursing.

Authors:  Ross Arena; Jonathan Myers; Mark A Williams; Martha Gulati; Paul Kligfield; Gary J Balady; Eileen Collins; Gerald Fletcher
Journal:  Circulation       Date:  2007-06-18       Impact factor: 29.690

4.  Impact of pulmonary hypertension on gas exchange and exercise capacity in patients with pulmonary fibrosis.

Authors:  Sven Gläser; Oliver Noga; Beate Koch; Christian F Opitz; Bernd Schmidt; Bettina Temmesfeld; Marcus Dörr; Ralf Ewert; Christoph Schäper
Journal:  Respir Med       Date:  2008-09-18       Impact factor: 3.415

5.  Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing.

Authors:  S Miyamoto; N Nagaya; T Satoh; S Kyotani; F Sakamaki; M Fujita; N Nakanishi; K Miyatake
Journal:  Am J Respir Crit Care Med       Date:  2000-02       Impact factor: 21.405

6.  Relationship between cardiac output and the end-tidal carbon dioxide tension.

Authors:  J P Ornato; A R Garnett; F L Glauser
Journal:  Ann Emerg Med       Date:  1990-10       Impact factor: 5.721

Review 7.  Cardiopulmonary exercise testing in the functional and prognostic evaluation of patients with pulmonary diseases.

Authors:  A M Ferrazza; D Martolini; G Valli; P Palange
Journal:  Respiration       Date:  2009-01-14       Impact factor: 3.580

8.  Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines.

Authors:  Michael McGoon; David Gutterman; Virginia Steen; Robin Barst; Douglas C McCrory; Terry A Fortin; James E Loyd
Journal:  Chest       Date:  2004-07       Impact factor: 9.410

9.  Impaired systemic oxygen extraction at maximum exercise in pulmonary hypertension.

Authors:  James Tolle; Aaron Waxman; David Systrom
Journal:  Med Sci Sports Exerc       Date:  2008-01       Impact factor: 5.411

10.  [Clinical-hemodynamic correlation of the NYHA/WHO system in idiopathic pulmonary artery hypertension. Clinical, therapeutic and long-term prognosis implications].

Authors:  Eulo Lupi Herrera; Julio Sandoval Zárate; Javier Figueroa Solano; Luis Efrén Santos Martínez; Tomás René Pulido Zamudio; Edgar Gildardo Bautista Bautista
Journal:  Arch Cardiol Mex       Date:  2008 Apr-Jun
View more
  12 in total

Review 1.  Pulmonary hypertension: NHLBI Workshop on the Primary Prevention of Chronic Lung Diseases.

Authors:  Eric D Austin; Steven M Kawut; Mark T Gladwin; Steven H Abman
Journal:  Ann Am Thorac Soc       Date:  2014-04

2.  Impact of pulmonary hypertension on exercise performance in patients with interstitial lung disease undergoing evaluation for lung transplantation.

Authors:  Hilary F Armstrong; P Christian Schulze; Matthew Bacchetta; Wilawan Thirapatarapong; Matthew N Bartels
Journal:  Respirology       Date:  2014-05-06       Impact factor: 6.424

Review 3.  Right ventricular dysfunction in chronic lung disease.

Authors:  Todd M Kolb; Paul M Hassoun
Journal:  Cardiol Clin       Date:  2012-05       Impact factor: 2.213

4.  Evaluation of end-tidal CO2 pressure at the anaerobic threshold for detecting and assessing pulmonary hypertension.

Authors:  Akifumi Higashi; Yoshihiro Dohi; Sayuri Yamabe; Hiroki Kinoshita; Yoshiharu Sada; Toshiro Kitagawa; Takayuki Hidaka; Satoshi Kurisu; Hideya Yamamoto; Yuji Yasunobu; Yasuki Kihara
Journal:  Heart Vessels       Date:  2017-05-30       Impact factor: 2.037

5.  EACPR/AHA Scientific Statement. Clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations.

Authors:  Marco Guazzi; Volker Adams; Viviane Conraads; Martin Halle; Alessandro Mezzani; Luc Vanhees; Ross Arena; Gerald F Fletcher; Daniel E Forman; Dalane W Kitzman; Carl J Lavie; Jonathan Myers
Journal:  Circulation       Date:  2012-09-05       Impact factor: 29.690

6.  Distinguishing exercise intolerance in early-stage pulmonary hypertension with invasive exercise hemodynamics: Rest VE /VCO2 and ETCO2 identify pulmonary vascular disease.

Authors:  Farhan Raza; Naga Dharmavaram; Timothy Hess; Ravi Dhingra; James Runo; Amy Chybowski; Callyn Kozitza; Supria Batra; Evelyn M Horn; Naomi Chesler; Marlowe Eldridge
Journal:  Clin Cardiol       Date:  2022-04-14       Impact factor: 3.287

7.  Association Between Hemodynamic Profile, Physical Capacity and Quality of Life in Pulmonary Hypertension.

Authors:  Diego de Faria Magalhães Torres; Walter Araujo Zin; Agnaldo José Lopes; Patrícia dos Santos Vigário; Marcelo Iorio Garcia; Daniel Waetge; Marcelo Luiz da Silva Bandeira; Luiz Gustavo Pignataro Bessa; Fernando Silva Guimarães
Journal:  Arq Bras Cardiol       Date:  2015-02-27       Impact factor: 2.000

8.  Impairment of pulmonary vascular reserve and right ventricular systolic reserve in pulmonary arterial hypertension.

Authors:  Enric Domingo; Juan C Grignola; Rio Aguilar; Christian Arredondo; Nadia Bouteldja; Manuel López Messeguer; Antonio Roman
Journal:  BMC Pulm Med       Date:  2014-04-24       Impact factor: 3.317

9.  Should cardiopulmonary exercise testing become a part of regular evaluation for patients with a family history of pulmonary hypertension? Regarding "Cardiopulmonary exercise testing reveals onset of disease and response to treatment in a case of heritable pulmonary arterial hypertension".

Authors:  Abraham Samuel Babu; Ross Arena; Arun G Maiya; Ramachandran Padmakumar; Marco Guazzi
Journal:  Pulm Circ       Date:  2013-01       Impact factor: 3.017

Review 10.  A review of ongoing trials in exercise based rehabilitation for pulmonary arterial hypertension.

Authors:  Abraham Samuel Babu; Ramachandran Padmakumar; Arun G Maiya
Journal:  Indian J Med Res       Date:  2013-05       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.